FDA Safety Initiatives Could Suffer Under Trump's Budget Proposal
Executive Summary
User fee-heavy budget proposes appears to tie into Trump's broader deregulatory strategy; CDER and CBER would have to make cuts to non-user fee safety initiatives.
You may also be interested in...
Trump's Budget Surprise: FDA Gets 13% Increase
President Trump's FY 2019 budget request includes $473m in new non-user fee revenue for the US agency, a reversal of the previous year's request.
Trump's Budget Surprise: FDA Gains 13% Increase
President Trump's FY 2019 budget request includes $473m in new non-user fee revenue for the US agency, a reversal of the previous year's request.
OMB's Grogan Talks Drug Pricing And Taking On 'Sacred Cows'
Concerns with promoting competition and reducing consumers' 'pain in the pocketbook' are key tenets of the Trump Administration's approach to lowering prescription drug pricing, Grogan says.